{"DataElement":{"publicId":"5615604","version":"1","preferredName":"Ann Arbor Clinical Stage","preferredDefinition":"Text term that represents the clinical stage for lymphoma using the Ann Arbor Lymphoma Staging System.","longName":"ann_arbor_clinical_stage","context":"GDC","contextVersion":"1","DataElementConcept":{"publicId":"5615484","version":"1","preferredName":"Lymphoma Clinical Ann Arbor Lymphoma Staging System","preferredDefinition":"A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas._Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._The Ann Arbor system classifies lymphoma into four stages based on anatomic lymph nodal group involvement. Disease confined to one nodal group or location defines stage I. Disease limited to one side of the diaphragm, (the muscle separating the chest from the abdomen), defines stage II. Stage III patients have disease on both sides of the diaphragm and stage IV patients once again have disseminated disease. Consideration of involvement of the liver, spleen, and bone marrow are also considered in this system. Finally, the stage is subdivided into categories of A and B depending on the presence of symptoms of itching, weight loss, fever, and night sweats. Those having symptoms receive the designation \"B\" and have a worse prognosis.","longName":"2475110v1.0:5615482v1.0","context":"GDC","contextVersion":"1","ObjectClass":{"publicId":"2475110","version":"1","preferredName":"Lymphoma","preferredDefinition":"A malignant (clonal) proliferation of B- or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites.  This category includes Non-Hodgkin's lymphomas and Hodgkin's lymphomas. -- 2003","longName":"C3208","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphoma","conceptCode":"C3208","definition":"A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"11901624-1EB2-3055-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-16","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-04-16","modifiedBy":"ONEDATA","dateModified":"2006-04-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5615482","version":"1","preferredName":"Clinical Ann Arbor Lymphoma Staging System","preferredDefinition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.:The Ann Arbor system classifies lymphoma into four stages based on anatomic lymph nodal group involvement. Disease confined to one nodal group or location defines stage I. Disease limited to one side of the diaphragm, (the muscle separating the chest from the abdomen), defines stage II. Stage III patients have disease on both sides of the diaphragm and stage IV patients once again have disseminated disease. Consideration of involvement of the liver, spleen, and bone marrow are also considered in this system. Finally, the stage is subdivided into categories of A and B depending on the presence of symptoms of itching, weight loss, fever, and night sweats. Those having symptoms receive the designation \"B\" and have a worse prognosis.","longName":"C25398:C54179","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Ann Arbor Lymphoma Staging System","conceptCode":"C54179","definition":"The Ann Arbor system classifies lymphoma into four stages based on anatomic lymph nodal group involvement. Disease confined to one nodal group or location defines stage I. Disease limited to one side of the diaphragm, (the muscle separating the chest from the abdomen), defines stage II. Stage III patients have disease on both sides of the diaphragm and stage IV patients once again have disseminated disease. Consideration of involvement of the liver, spleen, and bone marrow are also considered in this system. Finally, the stage is subdivided into categories of A and B depending on the presence of symptoms of itching, weight loss, fever, and night sweats. Those having symptoms receive the designation \"B\" and have a worse prognosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"455F21FE-6DF2-565C-E053-F662850A115D","latestVersionIndicator":"Yes","beginDate":"2017-01-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-05","modifiedBy":"ONEDATA","dateModified":"2017-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"455F21FE-6E03-565C-E053-F662850A115D","latestVersionIndicator":"Yes","beginDate":"2017-01-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-05","modifiedBy":"COOPERM","dateModified":"2020-08-17","changeDescription":"Created for GDC new CDE request. mc 1/5/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6154666","version":"1","preferredName":"Ann Arbor Clinical Stage","preferredDefinition":"The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"6154666v1.0","context":"GDC","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Stage I","valueDescription":"Ann Arbor Clinical Stage I","ValueMeaning":{"publicId":"5118557","version":"1","preferredName":"Ann Arbor Clinical Stage I","longName":"5118557","preferredDefinition":"A clinical stage that refers to lymphoma involving a single lymph node region or a single extranodal organ (Ie).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ann Arbor Clinical Stage I","conceptCode":"C125472","definition":"A clinical stage that refers to lymphoma involving a single lymph node region or a single extranodal organ (Ie).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2AE5E9B0-8CFB-D3CC-E050-BB89AD4301C1","latestVersionIndicator":"Yes","beginDate":"2016-02-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"687742F6-A975-6D1B-E053-F662850AE7E1","beginDate":"2016-02-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-28","modifiedBy":"ONEDATA","dateModified":"2018-03-28","deletedIndicator":"No"},{"value":"Stage II","valueDescription":"Ann Arbor Clinical Stage II","ValueMeaning":{"publicId":"5118558","version":"1","preferredName":"Ann Arbor Clinical Stage II","longName":"5118558","preferredDefinition":"A clinical stage that refers to lymphoma involving two or more node regions on the same side of the diaphragm or a single extranodal organ plus its regional lymph nodes with or without other nodes on the same side of the diaphragm (IIe).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ann Arbor Clinical Stage II","conceptCode":"C125474","definition":"A clinical stage that refers to lymphoma involving two or more node regions on the same side of the diaphragm or a single extranodal organ plus its regional lymph nodes with or without other nodes on the same side of the diaphragm (IIe).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2AE5E9B0-8D20-D3CC-E050-BB89AD4301C1","latestVersionIndicator":"Yes","beginDate":"2016-02-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"687742F6-A989-6D1B-E053-F662850AE7E1","beginDate":"2016-02-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-28","modifiedBy":"ONEDATA","dateModified":"2018-03-28","deletedIndicator":"No"},{"value":"Stage III","valueDescription":"Ann Arbor Clinical Stage III","ValueMeaning":{"publicId":"5118559","version":"1","preferredName":"Ann Arbor Clinical Stage III","longName":"5118559","preferredDefinition":"A clinical stage that refers to lymphoma involving node regions on both sides of the diaphragm, or an extralymphatic organ or site plus nodes on both sides of the diaphragm (IIIe), or lymph nodes on both sides of the diaphragm plus spleen (IIIs).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ann Arbor Clinical Stage III","conceptCode":"C125476","definition":"A clinical stage that refers to lymphoma involving node regions on both sides of the diaphragm, or an extralymphatic organ or site plus nodes on both sides of the diaphragm (IIIe), or lymph nodes on both sides of the diaphragm plus spleen (IIIs).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2AE5E9B0-8D45-D3CC-E050-BB89AD4301C1","latestVersionIndicator":"Yes","beginDate":"2016-02-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"687742F6-A99D-6D1B-E053-F662850AE7E1","beginDate":"2016-02-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-28","modifiedBy":"ONEDATA","dateModified":"2018-03-28","deletedIndicator":"No"},{"value":"Stage IV","valueDescription":"Ann Arbor Clinical Stage IV","ValueMeaning":{"publicId":"5118563","version":"1","preferredName":"Ann Arbor Clinical Stage IV","longName":"5118563","preferredDefinition":"A clinical stage that refers to diffuse extralymphatic involvement by lymphoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ann Arbor Clinical Stage IV","conceptCode":"C125478","definition":"A clinical stage that refers to diffuse extralymphatic involvement by lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2AE5E9B0-8DD9-D3CC-E050-BB89AD4301C1","latestVersionIndicator":"Yes","beginDate":"2016-02-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-02-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"687742F6-A9B1-6D1B-E053-F662850AE7E1","beginDate":"2016-02-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-28","modifiedBy":"ONEDATA","dateModified":"2018-03-28","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2960664","version":"1","preferredName":"Unknown","longName":"2960664","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"78485FBD-4C65-D67B-E040-BB89AD432E0E","latestVersionIndicator":"Yes","beginDate":"2009-11-13","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-11-13","modifiedBy":"KUMMEROA","dateModified":"2023-12-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ADC96DFE-C8C3-68E5-E053-4EBD850A039C","beginDate":"2020-08-26","endDate":null,"createdBy":"COLBERTM","dateCreated":"2020-08-26","modifiedBy":"ONEDATA","dateModified":"2020-08-26","deletedIndicator":"No"},{"value":"Not Reported","valueDescription":"Not Reported","ValueMeaning":{"publicId":"2572231","version":"1","preferredName":"Not Reported","longName":"2572231","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E734-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-11-16","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ADC96DFE-C8CD-68E5-E053-4EBD850A039C","beginDate":"2020-08-26","endDate":null,"createdBy":"COLBERTM","dateCreated":"2020-08-26","modifiedBy":"ONEDATA","dateModified":"2020-08-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2428501","version":"1","preferredName":"Stage","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"053C2A34-089B-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"GDC:NCI Genomic Data Commons","workflowStatus":"RELEASED","registrationStatus":"Application","id":"687742F6-A953-6D1B-E053-F662850AE7E1","latestVersionIndicator":"Yes","beginDate":"2018-03-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-28","modifiedBy":"COLBERTM","dateModified":"2020-08-26","changeDescription":"Created for Quick Question requested by T. Lichtenberg. 3.27.18 mc   Confirmed list and released VD after verification of the property in the GDC data dictionary. 8/26/20 MRC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5428034","version":"1","longName":"Clinical","context":"GDC","ClassificationSchemeItems":[{"publicId":"10000695","version":"1","longName":"Diagnosis","context":"GDC"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Ann Arbor Clinical Stage","type":"Preferred Question Text","description":"Ann Arbor Clinical Stage","url":null,"context":"GDC"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"45615922-B335-4DE4-E053-F662850A12A3","latestVersionIndicator":"Yes","beginDate":"2017-01-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-05","modifiedBy":"COLBERTM","dateModified":"2020-08-26","changeDescription":"Created for new CDE request. mc 1/5/17 Changed VD per request by T. Lichtenberg to separate out clinical and pathologic stages. 3.28.18 mc   Released DE after verification of the property in the GDC data dictionary. 8/26/20 MRC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}